Skip navigation

Professor Ignacio Anegon

Ignacio Anegon has over 25 years of experience as an immunologist. He is an expert in immunoregulation and functional genomics and has specialized in organ transplantation. Ignacio Anegon is a director at the Institut national de la santé et de la recherche médicale (INSERM) in Nantes, where he conducts research into immune tolerance induction in organ transplantation with the use of tolerogenic dendritic cells and T CD8+ regulatory cells.


Education

  • 1982-85: Postdoctoral researcher, Department of Immunology, University Hospital Clinic de Barcelona, University of Barcelona, Spain
  • 1982: M.D., University of Uruguay


Professional History

  • Since 2006: Director INSERM Unit 643, Nantes, France
  • Nov-Dec 2005: Visiting research fellow, Mount Sinai School of Medicine, New York, USA
  • Since 2002: Director of Research, INSERM Unit 643, Nantes, France
  • 1989-02: Professor, INSERM Unit 211 and Unit 437, Nantes, France
  • 1988-89: Visiting research fellow, INSERM Unit 211, Nantes, France
  • 1985-88: Research associate, Wistar Institute, University of Pennsylvania, Philadelphia, USA
  • Professor, Programa de Desarollo de Ciencias Básicas of Uruguay (UNESCO)

 

Memberships

  • Superior Council of the National Fund for Scientific and Technological Development (FONDECYT) of Chile
  • Since 2008: Representative of the Commission on Life Sciences of the "Comité Consultatif Régional de la Recherche et du Développement Technologique" (CCRRDT)
  • Since 2008: Member of the Scientific Council of the Nantes School of Medicine
  • Since 2006: Advisory Board of the Millennium Nucleus on Immunology and Immunotherapy of Chile
  • Since 2006: Transplantation Society Country Leader for France
  • Since 2006: Basic Science Committee of the Transplantation Society
  • Since 2005: Commission "Amérique latine du Comité Universitaire de Relations Internationales de l'université de Nantes"
  • Since 2003: Basic Science Committee of the European Society for Organ Transplantation
  • Since 2003: Scientific Council of OUEST-Génopole
  • 2008-11: Member of COSAS (Commission Opérationale de Suivi et d'Analyse Scientifique) du projet CPER Région Pays de la Loire
  • 2007-11: Member of the ESOT General Council as representative of the Basic Science Committee
  • 2005-07: Elected member (collège directeurs de recherche) to the General Council of the Nantes School of Medicine
  • 2005-09: Comité d'Orientation Stratégiques et de Suivi des Essais Cliniques (Cossec) enbiothérapies de l'INSERM
  • 2002-03: Coordinateur de la plate-forme Exploration Fonctionelle de l'Ouest-Génopole


Editorships

  • Since 2008: The Transplantation Journal
  • Since 2008: The Open Chemical and Biomedical Methods Journal
  • Since 2007: The Open Hematology Journal
  • Since 2007: The Open Biology Journal Since 2007: The Open Biotechnology Journal
  • Since 2007: The Current Opinion in Biotechnology
  • Since 2006: Hepatobiliary & Pancreatic Diseases International
  • Since 2005: Transgenic Research Since 2004: Editor-in-Chief, Current Gene Therapy
  • Since 1997: European Cytokine Network
  • 2000-04: Transplantation
  • 2001-03: Current Gene Therapy
  • 1993-00: Immunologia